Tandem Diabetes Care (TNDM) Shares Outstanding (2013 - 2026)

Tandem Diabetes Care's Shares Outstanding (Entity) history runs 10 years deep, the most recent figure standing at $68.5 million for Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 2.91% year-over-year to $68.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.5 million (up 2.91% YoY) and the FY2024 annual result came in at $66.3 million, up 1.09% from the prior year.
• Shares Outstanding (Entity) was $68.5 million for Q1 2026 at Tandem Diabetes Care, up from $67.8 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $68.5 million in Q1 2026 and bottomed at $63.9 million in Q1 2022.
• A 5-year average of $65.6 million and a median of $65.3 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) dropped 0.07% — and 2025, when it grew 3.24%.
• Tandem Diabetes Care's Shares Outstanding (Entity) stood at $64.5 million in 2022, then climbed by 1.61% to $65.6 million in 2023, then gained by 1.09% to $66.3 million in 2024, then gained by 2.28% to $67.8 million in 2025, then rose by 1.08% to $68.5 million in 2026.
• Business Quant data shows TNDM's Shares Outstanding (Entity) at $68.5 million in Q1 2026, $67.8 million in Q3 2025, and $67.5 million in Q2 2025.